Evolus Inc (NASDAQ:EOLS)

11.69
Delayed Data
As of May 24
 +0.04 / +0.34%
Today’s Change
5.06
Today|||52-Week Range
14.34
+79.57%
Year-to-Date

Today’s Trading

Previous close11.65
Today’s open11.81
Day’s range11.65 - 11.87
Volume21,818
Average volume (3 months)525,948
Market cap$679.9M
Data as of 4:00pm ET, 05/24/2022

Growth & Valuation

Earnings growth (last year)+80.54%
Earnings growth (this year)+7.48%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+76.29%
P/E ratioNM
Price/Sales3.25
Price/Book8.23

Competitors

----
SVASinovac Biotech Ltd----
QTRXQuanterix Corp-0.41-2.41%
----
Data as of 4:00pm ET, 05/24/2022

Financials

Next reporting dateAugust 4, 2022
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$99.7M
Annual profit (last year)-$46.8M
Net profit margin-46.96%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Newport Beach, California

Forecasts